Navigation Links
Washington Life Sciences Discovery Fund announces grants to commercialize promising technologies
Date:2/8/2011

SEATTLE, Washington, February 8, 2011 The Life Sciences Discovery Fund (LSDF) today announced nearly $600,000 in awards to support commercial development of technologies to improve the diagnosis and management of major health conditions.

Two of the four new grants are aimed at producing novel tests to diagnose or monitor disease. Jane Burns at Seattle Children's Hospital, in conjunction with Enertechnix, a Washington-based company, will adapt a novel air sampling device to collect exhaled breath for non-invasive detection of lung infections. Patrick Stayton at the University of Washington will develop new reagents to increase the speed and sensitivity of laboratory tests (known as immunoassays) used for diagnosing and monitoring disorders such as cancer and heart disease.

The remaining two grants focus on better management of neurological conditions. Christopher Bernards at Benaroya Research Institute at Virginia Mason will test a device, developed by the University of Washington and Seattle-based Impel NeuroPharma, that delivers drugs directly to the brain, potentially reducing harmful side effects. Barry Lutz at the University of Washington will use his award to develop an improved drainage system to reduce intracranial pressure in patients with brain disorders or trauma.

The awards were made in the second round of the 2010 commercialization grant competition, which promotes the translation of promising technologies from Washington's non-profit research sector into marketable products and services having the power to improve health, foster economic growth, and enhance life sciences competitiveness in the state.

"The Board of Trustees was particularly impressed with the 'platform potential' of these awards," noted LSDF executive director Lee Huntsman. "These are multi-application technologies. Even though the LSDF grant may focus on use for a single purpose, such as detecting bacteria in cystic fibrosis patients or reducing pain, each technology could have much broader applicability for diagnosing or treating a wide array of patients. This significantly enhances the potential for commercial success and for improving health and health care in Washington and beyond."

Commercialization grants are intended to boost technologies trapped in the so-called "valley of death" (that portion of the product development cycle in which funding is the most difficult to obtain) and make them more amenable to funding from the private sector. Tom Clement, Director of New Ventures-Life Sciences at the University of Washington Center for Commercialization (C4C), stated that "LSDF commercialization grants are a key component of C4C's mission of moving research discoveries out of the lab and into people's lives. These grants support proof-of-concept studies and other critical activities that help our Entrepreneurs-in-Residence and other expert advisors guide research outcomes into products to improve human health."

The four awards were chosen from the 10 proposals received in the competition. A panel of national experts convened by the American Association for the Advancement of Science evaluated the scientific and technical merit of the projects, while a panel of commercialization experts assessed each project's commercial potential and possible health and economic benefits. The LSDF Board of Trustees made the final award selections.

According to Lura Powell, chair of the LSDF Board of Trustees, getting new technologies into widespread use usually includes forming new companies or establishing partnerships with existing companies. Each of the four awards involves or anticipates the launch of a Washington-based company, in line with LSDF's mission to enhance the Washington economy. "These young technologies will not have an impact on human health without company involvement. We are pleased to use our commercialization grant funding to both move the technologies forward and encourage the development of Washington's for-profit life sciences sector," she stated.


'/>"/>

Contact: Cathy Manner
manner@lsdfa.org
206-732-6755
Life Sciences Discovery Fund
Source:Eurekalert

Related medicine news :

1. Eastern Washington Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign
2. Highlights of major physics conference in Washington, D.C.
3. Vancouver, Washington -- Free Family Fun at Health Fair
4. Ricochet PR Names Valerie Carter Vice President of Washington, D.C. Public Affairs Practice
5. New Insurance Membership Program Protects Washington State Families Against High Cost of Emergency Medical Transports
6. Brain Injury Association of Washington Provides National Leadership in Concussion Safety & Awareness
7. AMA Honors Washington State Secretary of Health With Top Government Service Award
8. Congressional Concession On Medical Malpractice Awards Will Not Lower Health Care Costs And Will Hurt Patients' Rights, Washington, DC Attorney Says
9. LazyTown Sportacus and Michelle Obama moves Washington DC
10. IntraHealth International Opens Washington, D.C. Office
11. DC Dermatologist Dr. Susan T. Elliott Selected Best Doctor by Washingtonian Magazine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes ... a mock evacuation of the facility as part of a disaster drill on October ... Hose EMS and Shelton City Emergency Manager, as well as the Connecticut Long ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at ... of the most popular and least understood books in the Holy Scriptures, Revelation. The ... that have baffled scholars for centuries. Many have tossed it off as mere rubbish, ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), an ... showcase a range of technology and learning solutions at the 68th Annual American ... to be held October 14–18, 2017 at the Mandalay Bay Resort in Las ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
(Date:10/12/2017)... ... 2017 , ... Leading pediatric oncology experts at Children’s National Health System ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of ...
Breaking Medicine News(10 mins):
(Date:9/19/2017)... ZirMed Inc ., a recognized leader in cloud-based revenue cycle ... ranked #1 by its users for the seventh consecutive year ... ZirMed was recognized as the top-ranked end-to-end revenue cycle management ... 200 beds and holds one of the longest #1 ranking ... ...
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis ... global supply chains, has published the first annual edition of its Global ... more than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that ... ... Risk & Performance Index ...
Breaking Medicine Technology: